ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2

Song, Zhenghui; Liu, Xinhui; Zhang, Wan; Luo, Yue; Xiao, Hua; Liu, Yun; Dai, Guanqi; Hong, Jian*; Li, Aimin*南方医科大学
Journal of Translational Medicine2022-4-5DOI: 10.1186/s12967-022-03366-y
6被引8阅读
引用收藏
分享

摘要

Background JAK1 and JAK2 have been implicated in fibrosis and cancer as a fibroblast-related marker; however, their role in liver fibrosis has not been elucidated. Here, we aim to determine the effect and underlying mechanism of JAK1/2 inhibition on liver fibrosis and hepatic stellate cells (HSCs) and further explore the therapeutic efficacy of Ruxolitinib, a JAK1/2 selective inhibitor, on preventing and reversing liver fibrosis in mice. Methods Immunohistochemistry staining of JAK1 and JAK2 were performed on liver tissue in mice with hepatic fibrosis and human liver tissue microarray of liver cirrhosis and liver cancer. LX-2 cells treated with specific siRNA of JAK1 and JAK2 were used to analysis activation, proliferation and migration of HSCs regulated by JAK1/2. The effects of Ruxolitinib (JAK1/2 inhibitor) on liver fibrosis were studied in LX-2 cells and two progressive and reversible fibrosis animal models (carbon tetrachloride (CCl4), Thioacetamide (TAA)). Results We found that JAK1/2 expression was positively correlated with the progression of HCC in humans and the levels of liver fibrosis in mice. Silencing of JAK1/2 down-regulated their downstream signaling and inhibited proliferation, migration, and activation of HSCs in vitro, while Ruxolitinib had similar effects on HSCs. Importantly, Ruxolitinib significantly attenuated fibrosis progression, improved cell damage, and accelerated fibrosis reversal in the liver of mice treated with CCl4 or TAA. Conclusions JAK1/2 regulates the function of HSCs and plays an essential role in liver fibrosis and HCC development. Its inhibitor, Ruxolitinib, may be an effective drug for preventing and treating liver fibrosis.

学科与关键词

关键词
Janus Kinase 1Janus Kinase 2Liver FibrosisHSCsRuxolitinib
相关
加载中…
  • Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib
    Guo, Hongrui; Liang, Shuhang; Wang, Yan; Zhou, Shuo; Yin, Dalong; Zhang, Shugeng; Wang, Jizhou; Wu, Dehai; Ma, Kun; Liu, Yufeng; Sun, Linmao; Ji, Changyong; Li, Xianying; Zhou, Huanran; Yang, Guangchao; Guo, Xinyu; Cui, Tianming; Li, Zihao; Liu, Yao; Wang, Jiabei*; Liu, Lianxin*Cell Death & Disease, 2022, 13(7): 623.被引 4
  • Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
    Song, Nazi; Xu, Hongjiao; Liu, Jiahua; Zhao, Qian; Chen, Hui; Yan, Zhibin; Yang, Runling; Luo, Zhiteng; Liu, Qi; Ouyang, Jianmei; Wu, Shuohan; Luo, Suijia; Ye, Shuyin; Lin, Runfeng; Sun, Xi; Xie, Junqiu; Lan, Tian; Wu, Zhongdao*; Wang, Rui*; Jiang, Xianxing*Acta Pharmaceutica Sinica B, 2022, 12(5): 2443-2461.被引 9
  • Kinetin inhibits hepatic stellate cell activation and induces apoptosis via interactions with the TGF-I31/Smad signaling pathway
    Jin, Fu-chang; Chen, Jing-jing; Xu, Qiu-xian; Zhou, Ming-Hui; Lin, Yi; Zhang, Qi-wei; Zhang, Chang-chun; Zhang, Zhen-gang*Toxicology and Applied Pharmacology, 2023, 475: 116655.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2022-04-05
卷期
第 20 卷, 第 1 期
页码
157
DOI
10.1186/s12967-022-03366-y
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20203006]; Science and Technology Program of Guangzhou, China [202002030075]; President's fund of Integrated hospital of traditional Chinese Medicine [1201902004]

作者

  • S

    Song, Zhenghui (第一作者)

    southern med univ

  • L

    Liu, Xinhui

    southern med univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Wan

    southern med univ

  • L

    Luo, Yue

    southern med univ

  • X

    Xiao, Hua

  • L

    Liu, Yun

    xiangnan univ

  • D

    Dai, Guanqi

    southern med univ

  • H

    Hong, Jian (通讯)

  • L

    Li, Aimin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417